Tarun Keswani1, Aisha Obeidallah1, Edward Nieves2, Simone Sidoli2, Melissa Fazzari3, Terrie Taylor4,5, Karl Seydel4,5, Johanna P Daily1,6. 1. Department of Microbiology and Immunology, Albert Einstein College of Medicine, Bronx, New York, USA. 2. Department of Biochemistry, Albert Einstein College of Medicine, Bronx, New York, USA. 3. Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, New York, USA. 4. Blantyre Malaria Project, Kamuzu University of Health Sciences, Blantyre, Malawi. 5. Department of Osteopathic Medical Specialties, College of Osteopathic Medicine, Michigan State University, East Lansing, Michigan, USA. 6. Infectious Diseases, Department of Medicine, Albert Einstein College of Medicine, Bronx, New York, USA.
Abstract
BACKGROUND: We explored a metabolic etiology of cerebral malaria (CM) coma. METHODS: Plasma metabolites were compared between Malawian children with CM and mild Plasmodium falciparum malaria. A candidate molecule was further studied in animal models of malaria. RESULTS: Clinically abnormal concentrations of pipecolic acid (PA) were present in CM plasma, and nearly normal in mild malaria samples. PA is renally cleared and the elevated PA blood levels were associated with renal insufficiency, which was present only in CM subjects. Prior studies demonstrate that PA has neuromodulatory effects and is generated by malaria parasites. PA brain levels in Plasmodium berghei ANKA-infected animals in the experimental cerebral malaria (ECM) model inversely correlated with normal behavior and correlated with blood-brain barrier (BBB) permeability. Mice infected with malaria species that do not induce neurological abnormalities or manifest BBB permeability had elevated plasma PA levels similar to ECM plasma at 7 days postinfection; however, they had low PA levels in the brain compared to ECM mice brains at 7 days postinfection. CONCLUSIONS: Our model suggests that malaria-generated PA induces coma in CM and in ECM. The role of BBB permeability and the mechanisms of PA neuromodulation in CM will require additional investigation.
BACKGROUND: We explored a metabolic etiology of cerebral malaria (CM) coma. METHODS: Plasma metabolites were compared between Malawian children with CM and mild Plasmodium falciparum malaria. A candidate molecule was further studied in animal models of malaria. RESULTS: Clinically abnormal concentrations of pipecolic acid (PA) were present in CM plasma, and nearly normal in mild malaria samples. PA is renally cleared and the elevated PA blood levels were associated with renal insufficiency, which was present only in CM subjects. Prior studies demonstrate that PA has neuromodulatory effects and is generated by malaria parasites. PA brain levels in Plasmodium berghei ANKA-infected animals in the experimental cerebral malaria (ECM) model inversely correlated with normal behavior and correlated with blood-brain barrier (BBB) permeability. Mice infected with malaria species that do not induce neurological abnormalities or manifest BBB permeability had elevated plasma PA levels similar to ECM plasma at 7 days postinfection; however, they had low PA levels in the brain compared to ECM mice brains at 7 days postinfection. CONCLUSIONS: Our model suggests that malaria-generated PA induces coma in CM and in ECM. The role of BBB permeability and the mechanisms of PA neuromodulation in CM will require additional investigation.
Authors: Aakash Shrivastava; Anil Kumar; Jerry D Thomas; Kayla F Laserson; Gyan Bhushan; Melissa D Carter; Mala Chhabra; Veena Mittal; Shashi Khare; James J Sejvar; Mayank Dwivedi; Samantha L Isenberg; Rudolph Johnson; James L Pirkle; Jon D Sharer; Patricia L Hall; Rajesh Yadav; Anoop Velayudhan; Mohan Papanna; Pankaj Singh; D Somashekar; Arghya Pradhan; Kapil Goel; Rajesh Pandey; Mohan Kumar; Satish Kumar; Amit Chakrabarti; P Sivaperumal; A Ramesh Kumar; Joshua G Schier; Arthur Chang; Leigh Ann Graham; Thomas P Mathews; Darryl Johnson; Liza Valentin; Kathleen L Caldwell; Jeffery M Jarrett; Leslie A Harden; Gary R Takeoka; Suxiang Tong; Krista Queen; Clinton Paden; Anne Whitney; Dana L Haberling; Ram Singh; Ravi Shankar Singh; Kenneth C Earhart; A C Dhariwal; L S Chauhan; S Venkatesh; Padmini Srikantiah Journal: Lancet Glob Health Date: 2017-01-31 Impact factor: 26.763
Authors: Amit Bahl; Brian Brunk; Ross L Coppel; Jonathan Crabtree; Sharon J Diskin; Martin J Fraunholz; Gregory R Grant; Dinesh Gupta; Robert L Huestis; Jessica C Kissinger; Philip Labo; Li Li; Shannon K McWeeney; Arthur J Milgram; David S Roos; Jonathan Schug; Christian J Stoeckert Journal: Nucleic Acids Res Date: 2002-01-01 Impact factor: 16.971
Authors: Karl B Seydel; Samuel D Kampondeni; Clarissa Valim; Michael J Potchen; Danny A Milner; Francis W Muwalo; Gretchen L Birbeck; William G Bradley; Lindsay L Fox; Simon J Glover; Colleen A Hammond; Robert S Heyderman; Cowles A Chilingulo; Malcolm E Molyneux; Terrie E Taylor Journal: N Engl J Med Date: 2015-03-19 Impact factor: 91.245
Authors: Alister G Craig; Georges E Grau; Chris Janse; James W Kazura; Dan Milner; John W Barnwell; Gareth Turner; Jean Langhorne Journal: PLoS Pathog Date: 2012-02-02 Impact factor: 6.823
Authors: Thomas D Otto; Ulrike Böhme; Andrew P Jackson; Martin Hunt; Blandine Franke-Fayard; Wieteke A M Hoeijmakers; Agnieszka A Religa; Lauren Robertson; Mandy Sanders; Solabomi A Ogun; Deirdre Cunningham; Annette Erhart; Oliver Billker; Shahid M Khan; Hendrik G Stunnenberg; Jean Langhorne; Anthony A Holder; Andrew P Waters; Chris I Newbold; Arnab Pain; Matthew Berriman; Chris J Janse Journal: BMC Biol Date: 2014-10-30 Impact factor: 7.431
Authors: Andrea L Conroy; Robert O Opoka; Paul Bangirana; Richard Idro; John M Ssenkusu; Dibyadyuti Datta; James S Hodges; Catherine Morgan; Chandy C John Journal: BMC Med Date: 2019-05-21 Impact factor: 8.775